The long-acting drug delivery technologies market is projected to grow at a CAGR of 13%, till 2035, claims Roots Analysis
In order to mitigate the complexities associated with achieving a long-acting profile, drug developers have been inclined towards the utilization of long-acting drug delivery technologies and outsourcing certain operations to service providers.London
Roots Analysis has announced the addition of “Long-Acting Drug Delivery Technologies and Services Market, 2023-2035” report to its list of offerings.
The conventional treatment options available for several diseases are known to be associated with several challenges, such as patient non-compliance, non-adherence to medication and multiple dosing regimen. In order to circumvent the abovementioned challenges, the demand for long-acting drugs is increasing. The development and manufacturing of these novel pharmacological modalities require advanced long-acting drug delivery technologies and dedicated expertise available with service providers. It is worth mentioning that 70% of the technologies are compatible with injectables (depot and long-acting injections)
Key Market Insights
Over 110 long-acting drug delivery technologies are available, globally
Majority (28%) of the technologies are based on long-acting implants / devices, followed by those based on micro-encapsulation (24%). In addition, close to 40% of the technologies that are compatible with injectables can extend the dosing regimen up to months.
Over 40 companies claim to offer long-acting drug delivery contract services
Presently, the market is dominated by the presence of small (2-50 employees) and mid-sized (51-200 employees) players, who represent 70% of the contemporary market landscape. Notably, around 35% of the total players engaged in this space offer their services at all scales of operation.
Partnership activity in this domain has increased at a CAGR of ~10%, between 2018 and 2021
Maximum number of partnerships were inked in 2021 and 2022, indicating a recent rise in partnership activity. Majority of the deals were acquisitions (15%), followed by product development and technology licensing agreements (14%, each).
More than 570 articles focused on long-acting drug delivery, have been published in reputed scientific journals, since 2017
Around 85% of the publications were focused on research related to long-acting drug delivery. This is indicative of the extensive research activity being carried out in this domain.
Over 1,200 patents have been filed / published related to long-acting drug delivery, since 2018
Over 45% of these were granted patents, while around 55% were patent applications. Further, majority of the patent assignees were industry players. However, it is worth mentioning that the contribution of non-industry players in the overall patent filing activity has increased considerably (CAGR of 10%), over the past few years.
More than 400 grants were awarded to support ongoing R&D activities in long-acting drug delivery, between 2018 and 2022
Collectively, the capital amount awarded to support R&D in this field was estimated to be worth USD 207.2 million. It is worth noting that 97 grants were awarded in 2021, alone. A significant proportion of grants identified in the report (23%) were awarded under the NIH department of internal medicine, followed by those awarded under the department of biomedical engineering (16%).
Increased access to advanced technologies is anticipated to drive growth in this market at a CAGR of 13%, till 2035
Long-acting drug delivery technologies developed for the delivery of small molecules are likely to capture the highest share (~82%) in the market; this trend is unlikely to change in the foreseen future.
Long-acting drug delivery services market is expected to grow at a CAGR of 11%, till 2035
Based on compatible dosage form, majority of the revenue share (50%) is likely to be associated with injectables. On the other hand, the services market for vaginal dosage forms is expected to grow at a faster pace (CAGR of 11.9%), during the forecasted period.
To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/....reports/long-acting-
Frequently Asked Questions
What are the major factors driving the long-acting drug delivery technologies and services market?
How many long-acting drug delivery technologies, compatible with long-acting injectables, are available in the market?
How many long-acting drug delivery technologies demonstrate extended dosage regimen of at least a year?
How many long-acting drug delivery technologies demonstrate extended dosage regimen of at least a year?
How many contract service providers possess technology transfer capabilities related to long-acting drug delivery?
What are the partnership and collaboration trends in the long-acting drug delivery domain?
What is the current patent landscape of long-acting drug delivery market?
Which segment, in terms of strategy, accounts for the largest share in the global long-acting drug delivery technologies market?
Which geography is expected to witness the highest growth rate in the long-acting drug delivery services market?
The financial opportunity within the gene therapy market has been analyzed across the following segments:
Principle
Manipulation of drug release from delivery systems
Manipulation of in vivo clearance
Strategy
Chemical Modification
Micro-encapsulation
Long-Acting Hydrogels
Long-Acting Implants
Long-Acting Microneedles
Multivesicular Liposomes
Nanocrystal Suspensions
Protein Fusion
Compatible Dosage Form
Injectables
Implantables
Oral Dosage Forms
Topical / Transdermal Dosage Forms
Vaginal Dosage Forms
Other Dosage Forms
Type of Molecules Delivered
Small Molecules
Biologics
Other Molecules
Type of Material Used
Polymer based
Non-polymer based
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
The research includes brief profiles of key players (listed below) engaged in offering technologies and services related to long-acting drug delivery; each profile features a brief overview of the company, details related to its technology and service portfolio, recent developments and an informed future outlook.
Adare Pharma Solutions
AMW
Bostal Drug Delivery
Creative Biolabs
ForDoz Pharma
Innocore Pharmaceuticals
Integral BioSystems
LATITUDE Pharmaceuticals
Navin Saxena Research and Technology Centre (NSRT)
Samyang Biopharm
For additional details, please visit https://www.rootsanalysis.com/....reports/long-acting-
You may also be interested in the following titles:
1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035
2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
